Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Combe

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Annals of the Rheumatic Diseases|February 28, 2012
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximabA Ruyssen-Witrand, S Rouanet, B Combe, et al.
Annals of the Rheumatic Diseases|May 4, 1999
Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritisG Hayem, M De Bandt, E Palazzo, et al.
Annals of the Rheumatic Diseases|July 3, 2007
Characteristics and survival of 26 patients with paraneoplastic arthritisJ Morel, V Deschamps, E Toussirot, et al.
Presse Medicale (Paris, France : 1983)|April 25, 1987
[Treatment of rheumatoid arthritis. Comparative study of the effect of immunoglobulins G eluted from the placenta and of venoglobulins]J Sany, J Clot, B Combe, et al.
Arthritis and Rheumatism|August 18, 2001
Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective studyB Combe, M Dougados, P Goupille, et al.
Arthritis and Rheumatism|December 1, 1994
Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patientsC Bologna, L Edno, J M Anaya, et al.
Arthritis and Rheumatism|September 10, 2011
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trialW Rigby, H-P Tony, K Oelke, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1994
[The risk/benefit ratio of low-dose cyclosporin in the treatment of severe rheumatoid arthritis]R M Flipo, P Bertin, B Combe, et al.
Arthritis and Rheumatism|July 1, 1996
Sicca syndrome associated with hepatitis C virus infectionC Jorgensen, M C Legouffe, P Perney, et al.
The Journal of Rheumatology|January 26, 1999
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritisG Hayem, P Chazerain, B Combe, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|February 28, 2012
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximabA Ruyssen-Witrand, S Rouanet, B Combe, et al.
Annals of the Rheumatic Diseases|May 4, 1999
Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritisG Hayem, M De Bandt, E Palazzo, et al.
Annals of the Rheumatic Diseases|July 3, 2007
Characteristics and survival of 26 patients with paraneoplastic arthritisJ Morel, V Deschamps, E Toussirot, et al.
Presse Medicale (Paris, France : 1983)|April 25, 1987
[Treatment of rheumatoid arthritis. Comparative study of the effect of immunoglobulins G eluted from the placenta and of venoglobulins]J Sany, J Clot, B Combe, et al.
Arthritis and Rheumatism|August 18, 2001
Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective studyB Combe, M Dougados, P Goupille, et al.
Arthritis and Rheumatism|December 1, 1994
Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patientsC Bologna, L Edno, J M Anaya, et al.
Arthritis and Rheumatism|September 10, 2011
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trialW Rigby, H-P Tony, K Oelke, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1994
[The risk/benefit ratio of low-dose cyclosporin in the treatment of severe rheumatoid arthritis]R M Flipo, P Bertin, B Combe, et al.
Arthritis and Rheumatism|July 1, 1996
Sicca syndrome associated with hepatitis C virus infectionC Jorgensen, M C Legouffe, P Perney, et al.
The Journal of Rheumatology|January 26, 1999
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritisG Hayem, P Chazerain, B Combe, et al.
Pageof 16